EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
The stunning country in Europe where it’s ’cheapest’ for a meal out – £17 for 2 | Europe | Travel
As prices continue to soar in many of Europe’s most popular hotspots, travellers are increasingly finding that a…